Shamis & Gentile, P.A. is investigating claims on behalf of investors of SelectQuote Inc (“SelectQuote” or the “Company”) (SLQT). Impacted investors are advised to contact the firm now.
The investigation concerns whether SelectQuote and certain of its officers and/or directors have allegedly engaged in securities fraud or other unlawful business practices.
The investigation focuses on events following the unsealing of a Department of Justice (DOJ) False Claims Act complaint on May 1, 2025, which alleges that SelectQuote and other large brokers received illegal kickbacks from major insurers in exchange for Medicare Advantage enrollments between 2016 and 2021. These allegations seemingly contradict prior Company statements describing SelectQuote’s agent advice as “unbiased” and its business as “needs-based.”
On this news, SelectQuote’s stock price fell $0.61 per share, or approximately 19%, to close at $2.56 on May 1, 2025. Over $127 million in market capitalization was erased within 48 hours, and trading volumes surged to nearly five times the recent average.
Shamis & Gentile, P.A. stands out as an advocate for investors who are victims of securities fraud. The firm is committed to securing recoveries for investors who have incurred damages due to false and misleading statements or other corporate misconduct by public companies. Shamis Gentile has recovered over $1 billion for consumers nationwide. Its extensive experience, expertise, and resources enable the firm to resolve disputes in a wide range of matters, including class actions, mass torts and mass arbitrations.
Attorney advertising. Prior results do not guarantee similar outcomes.
